Financials in USD. Standardized financial statements.
A compact view of how STAAR Surgical Company turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $239.44M | $313.90M | $322.42M | $284.39M | $230.47M | $163.46M | $150.19M | $123.95M | $90.61M | $82.43M |
| Revenue Growth? | -23.7% | -2.6% | +13.4% | +23.4% | +41.0% | +8.8% | +21.2% | +36.8% | +9.9% | 0.0% |
| Cost of Revenue? | $57.02M | $74.32M | $69.76M | $61.01M | $51.84M | $45.10M | $38.23M | $32.44M | $26.33M | $24.06M |
| Gross Profit? | $182.42M | $239.58M | $252.65M | $223.38M | $178.64M | $118.36M | $111.95M | $91.51M | $64.28M | $58.37M |
| Gross Margin? | +76.2% | +76.3% | +78.4% | +78.5% | +77.5% | +72.4% | +74.5% | +73.8% | +70.9% | +70.8% |
| Operating Expenses? | $228.37M | $252.19M | $224.55M | $179.58M | $145.30M | $111.59M | $100.10M | $84.92M | $67.91M | $71.02M |
| Operating Income? | -$45.95M | -$12.61M | $28.10M | $43.80M | $33.34M | $6.77M | $11.85M | $6.59M | -$3.63M | -$12.65M |
| EBITDA? | -$37.22M | -$5.72M | $33.22M | $48.31M | $36.98M | $9.86M | $15.55M | $9.06M | -$277,000 | -$9.66M |
| Income Before Tax | -$82.26M | -$9.05M | $33.70M | $45.55M | $31.30M | $8.27M | $13.03M | $6.64M | -$2.30M | -$12.44M |
| Income Tax Expense | -$1.81M | $11.16M | $12.35M | $5.89M | $3.79M | $2.35M | -$1.02M | $1.67M | -$157,000 | -$315,000 |
| Net Income? | -$80.45M | -$20.21M | $21.35M | $39.66M | $27.51M | $5.91M | $14.05M | $4.97M | -$2.14M | -$12.13M |
| EPS? | $-1.62 | $-0.41 | $0.44 | $0.83 | $0.52 | $0.13 | $0.32 | $0.11 | $-0.05 | $-0.30 |
| Diluted EPS? | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.50 | $0.12 | $0.30 | $0.11 | $-0.05 | $-0.30 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality